LVI_Logo Twitter Facebook LinkedIn

  • Home
  • About
  • Indications
  • Product
  • Newsroom
  • Resources

sub banner

Restoring Vision with a Protein-Based Artificial Retina

LambdaVision is developing the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significant sight due to advanced retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD).

Both RP and AMD lead to the breakdown and loss of cells in the retina. By using proteins similar to the visual pigment rhodopsin that is naturally found in our eyes, LambdaVision’s protein-based artificial retina mimics the light-absorbing properties of human photoreceptors replacing the function of these damaged cells in the retinas of blind patients.

Learn More

In the Media

LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station
Read more...

LambdaVision Secures Further NASA Funding to Utilize Company's Advanced Production Processes for Additional Applications
Read more...

New ISS National Lab Research Aims to Treat Blindness


Power of Possible: LambdaVision Retinal Implant


Inside UConn TIP Podcast Series





Tweets by LambdaVision

sub banner

Home | About | Indications | Product | News | Resources
 © 2020 LambdaVision, Inc. All Rights Reserved. Website by J. A. Greco.